Jump to: [Chinese Items]   [0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] or enter the first few letters:

Showing items 10001-10025 of 12972. (519 Page(s) Totally) << < 396 397 398 399 400 401 402 403 404 405 > >> View [10|25|50] records per page

Date	Title	Relation
2022-01	RamAp is an efflux pump regulator carried by an IncHI2 plasmid	Antimicrobial Agents and Chemotherapy. 2022 Jan 18;66(1):Article number e01152-21.
2020-02	Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study	Journal of Clinical Oncology. 2020 Feb;38(4):Meeting Abstract 477.
2013-11-06	Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma	PLoS ONE. 2013 Nov 6;8(11):Article number e79863.
2006-01	Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow.	Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow.
2013-01	Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma	Alimentary Pharmacology and Therapeutics. 2013 Jan;37(1):62-73.
2019-10	Randomised phase 3 study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC) - Integrate II	Annals of Oncology. 2019 Oct;30(Suppl. 6):137.
2010-09	A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients	British Journal of Cancer. 2010 Sep;103(7):954-960.
2004-02-26	A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated	British Journal of Cancer. 2004 Feb;90(2):359-365.
2007-08	A randomised placebo-controlled trial of a traditional chinese herbal formula in the treatment of primary dysmenorrhoea	PLoS ONE. 2007 Aug;2(8):Article number e719.
2004-03	Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer	British Journal of Surgery. 2004 Mar;91(3):283-287.
2024-11-15	A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access	Kidney International. 2024 Nov 15;Article in Press.
2019-03	Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients	American Journal of Clinical Nutrition. 2019 Mar;109(3):606-614.
2014-05	Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):TPS4148.
2007-06	A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan	Lung Cancer. 2007 Jun;56(3):363-369.
2013-06-21	A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma	Annals of Oncology. 2013 Jun 21;24(6):1567-1573.
2011-02	Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma	Journal of Clinical Oncology. 2011 Feb;29(Suppl. 4 ):Abstract Number 6
2005-03	A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated	Lung Cancer. 2005 Mar;47(3):373-380.
2012-05-20	Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial	Journal of Clinical Oncology. 2012 May 20;30(15 Suppl.):Abstract number TPS4149.
2003-02	A randomized trial comparing intravesical instillations of mitoxantrone and doxorubicin in patients with superficial bladder cancer	Chang Gung Medical Journal. 2003 Feb;26(2):91-97.
2006-04	A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy	Chest. 2006 Apr;129(4):1031-1038.
2010-04	A Randomized, Double-blind, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron plus Dexamethasone Injection for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting	Japanese Journal of Clinical Oncology. 2010 Apr;40(4):294-301.
2010-06	Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2010 Jun;21(Suppl. 6):27.
2009-05-20	Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587.
2018-10	Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 626PD.
2015-05	Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4101.

Showing items 10001-10025 of 12972. (519 Page(s) Totally) << < 396 397 398 399 400 401 402 403 404 405 > >> View [10|25|50] records per page